What’s Behind the Surge in Pharmaceutical Deals?
Aug. 25 (Bloomberg) –- Bloomberg’s Shannon Pettypiece discusses Roche’s $8.3 billion offer for InterMune and big pharmaceutical deals. She speaks on “Bottom Line.” (Source: Bloomberg)
Most Recent Videos
Steve Ballmer: Twitter Is an Irreproducible Asset
09:24 - Bloomberg Technology's Emily Chang sits down with former Microsoft CEO and Twitter shareholder Steve Ballmer in Stanford, California. (Source: Bloomberg)